Benjamin Dibling, Ph.D.
Project Manager
Edelstone Center
6030 S. Ellis Avenue, 2S
Chicago, IL 60637
Phone: 773-834-1270
Fax: 773-702-0741
bdibling@tech.uchicago.edu
Benjamin Dibling joined UChicagoTech in 2004. In his role as Project Manager, Ben is responsible for leading the identification, evaluation, protection and commercialization of inventions arising from University of Chicago research. Ben manages a large portfolio of technologies from diverse scientific disciplines with a heavy focus on oncology, diabetes, and infectious disease.
In addition to Ben’s work as a Project Manager at UChicagoTech, he also leads many other office initiatives, including outreach efforts designed to build relationships with University of Chicago faculty, as well as training and mentoring Associate Project Managers. Ben also works closely with University Research Administration to review licensing and confidentiality provisions in grant awards, material transfer, corporate sponsored, consulting, and clinical trial agreements.
Ben initially came to the University of Chicago in 2000 to conduct post-doctoral research at the Ben May Department of Cancer Research, where he investigated the regulation of cell death by JNK and NFκB signaling pathways and the regulation of cell death by retinoblastoma tumor suppressor gene. Ben also has prior industry experience developing novel anti-cancer agents within AstraZeneca’s signal transduction group in the United Kingdom.
Ben holds a Bachelor’s of Medical Science (Molecular and Cellular Biology) from the University of Birmingham, a Ph.D. in Clinical Medicine from the University of Leeds, and became a registered Patent Agent in 2009. Ben is originally from Saffron Walden, a small town in the United Kingdom.